Open Insider Trading Activity for Onkure Therapeutics, Inc. Chief Financial Officer Leverone Jason A.
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2026-06-24 | 2026-06-22 | Onkure Therapeutics, Inc. | Leverone Jason A. | Chief Financial Officer | Sell | 1 | 303 | $4.40 | $1,333.20 | 1.59% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2026-03-24 | 2026-03-23 | Onkure Therapeutics, Inc. | Leverone Jason A. | Chief Financial Officer | Sell | 1 | 301 | $4.16 | $1,252.16 | 1.85% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2025-12-23 | 2025-12-22 | Onkure Therapeutics, Inc. | Leverone Jason A. | Chief Financial Officer | Sell | 1 | 302 | $2.97 | $896.94 | 1.82% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2025-09-24 | 2025-09-22 | Onkure Therapeutics, Inc. | Leverone Jason A. | Chief Financial Officer | Sell | 1 | 303 | $2.62 | $793.86 | 2.35% | View Filing |